TREA

86045285

Follow

Information

  • Trademark
  • 86045285
  • Serial Number
    86045285
  • Registration Number
    4729961
  • Filing Date
    August 22, 2013
    11 years ago
  • Registration Date
    May 05, 2015
    9 years ago
  • Transaction Date
    December 28, 2021
    2 years ago
  • Status Date
    November 19, 2021
    2 years ago
  • Published for Opposition Date
    February 17, 2015
    9 years ago
  • Location Date
    May 05, 2015
    9 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SPARER, ZACHARY R
  • Attorney Docket Number
    815646.10002
    Attorney Name
    Joan K. Archer
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
2000
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of one smaller crescent shape inside of a larger crescent shape.
  • GS0051: Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders
  • GS0421: Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services; information, advisory and consultancy services relating to all the aforesaid services
Case File Event Statements
  • 11/19/2021 - 2 years ago
    44 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 5/5/2020 - 4 years ago
    43 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 5/5/2015 - 9 years ago
    42 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/17/2015 - 9 years ago
    41 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/17/2015 - 9 years ago
    40 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/28/2015 - 9 years ago
    39 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/12/2015 - 9 years ago
    38 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/12/2015 - 9 years ago
    37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/12/2015 - 9 years ago
    36 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/12/2015 - 9 years ago
    35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/12/2015 - 9 years ago
    34 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/12/2015 - 9 years ago
    33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/8/2015 - 9 years ago
    32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/8/2015 - 9 years ago
    31 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/8/2015 - 9 years ago
    30 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/2/2015 - 9 years ago
    29 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 12/16/2014 - 9 years ago
    28 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 12/4/2014 - 9 years ago
    27 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 12/1/2014 - 9 years ago
    26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/26/2014 - 9 years ago
    25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/26/2014 - 9 years ago
    24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/26/2014 - 9 years ago
    23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/26/2014 - 9 years ago
    22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/8/2014 - 10 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/7/2014 - 10 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/7/2014 - 10 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/7/2014 - 10 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/8/2014 - 10 years ago
    17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/8/2014 - 10 years ago
    16 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/8/2014 - 10 years ago
    15 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/6/2014 - 10 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/6/2014 - 10 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/25/2014 - 10 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 4/8/2014 - 10 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/8/2014 - 10 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/28/2013 - 11 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/28/2013 - 11 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/28/2013 - 11 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/28/2013 - 11 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/1/2013 - 11 years ago
    5 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/1/2013 - 11 years ago
    4 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/31/2013 - 11 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/30/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/26/2013 - 11 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP